Aygestin combined with Premarin

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Neoplasm Malignant Other Serious Female 1/11/2006 Consumer United States
Primary
Secondary
Ventricular Tachycardia Life Threatening 1/1/2003 62 Female 2/15/2006 Physician United States
Primary
Concomitant
Insomnia 12/1/2005 55 Female 2/27/2006 Consumer United States
Primary
Concomitant
Mood Swings Other Serious 9/1/2005 Female 140 lb 1/20/2006 United States
Primary
Concomitant
Progesterone Receptor Assay Positive Other Serious 4/27/2004 76 Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 Female 4/12/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 4/5/2004 60 Female 4/10/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 7/1/2001 Female 4/10/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/5/2004 59 Female 4/12/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 4/13/2006 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 4/19/2006 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 2/1/1997 72 Female 5/25/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 7/21/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2004 74 Female 7/21/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 75 Female 150 lb 8/17/2006 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/25/2004 Female 8/30/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 12/1/1999 Female 8/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/1/2000 75 Female 150 lb 11/13/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 5/9/2000 75 Female 150 lb 12/5/2006 Consumer United States
Primary
Secondary
Concomitant
Mastectomy Other Serious Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 3/26/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 11/1/2001 Female 3/20/2007 Lawyer United States
Primary
Secondary
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 66 Female 125 lb 7/9/2007 United States
Primary
Secondary
Breast Cancer Other Serious 2/17/1995 56 Female 8/14/2007 Consumer United States
Primary
Secondary
Ultrasound Breast Abnormal Other Serious 1/1/2000 11/3/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1993 59 Female 165 lb 9/17/2007 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Metastatic Other Serious 6/30/2000 Female 12/11/2007 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2001 Female 1/31/2008 Consumer United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 6/30/2000 Female 5/29/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Death Female 6/25/2008 United States
Primary
Secondary
Breast Cancer Female Death Female 7/16/2008 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 7/11/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 7/21/2008 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 10/1/1997 Female 7/18/2008 Lawyer United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 7/31/2008 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 7/28/2008 Lawyer United States
Primary
Secondary
Metastases To Bone Other Serious 12/16/2004 Female 167 lb 9/3/2008 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/1/1996 Female 9/4/2008 Lawyer United States
Primary
Secondary
Metastases To Bone Other Serious 12/16/2004 Female 167 lb 10/3/2008 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2000 64 Female 11/7/2008 Lawyer United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 1/14/2009 United States
Primary
Secondary
Injury Other Serious Female 1/17/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/1/1998 48 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Metastatic Other Serious 6/30/2000 Female 1/27/2009 Consumer United States
Primary
Secondary
Vision Blurred Other Serious 12/15/1994 Female 125 lb 1/28/2009 United States
Primary
Secondary
Breast Cancer Female Other Serious 12/3/2001 64 Female 12/19/2008 United States
Primary
Secondary
Myocardial Infarction Other Serious 1/1/1999 49 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 3/5/2002 57 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/1998 51 Female 12/19/2008 United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/2000 Female 3/24/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 5/1/1995 Female 124 lb 3/26/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 9/1/2000 Female 132 lb 3/26/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 12/1/1999 Female 3/27/2009 Lawyer United States
Primary
Secondary
Renal Failure Chronic Other Serious 5/27/1999 62 Female 3/23/2009 Lawyer United States
Primary
Concomitant
Breast Cancer Female Other Serious 6/1/2000 Female 170 lb 4/9/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/2/2000 Female 143 lb 4/9/2009 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/25/2004 Female 207 lb 4/15/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 6/30/2000 Female 170 lb 4/23/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/1994 5/4/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 5/18/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 12/1/2001 Female 5/20/2009 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious 1/1/2001 Female 139 lb 5/25/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/12/2001 Female 143 lb 6/10/2009 Lawyer United States
Primary
Secondary
Concomitant
Visual Acuity Reduced 5/15/2009 65 Female 6/17/2009 Consumer
Primary
Concomitant
Breast Cancer Female Other Serious 7/1/2001 Female 6/19/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 3/14/2003 Female 148 lb 6/19/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 7/21/2003 Female 130 lb 6/22/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/27/2004 Female 115 lb 7/13/2009 Lawyer United States
Primary
Secondary
Lung Neoplasm Malignant Other Serious 1/22/1999 Female 7/14/2009 Lawyer United States
Primary
Secondary
Visual Acuity Reduced 5/15/2009 65 Female 8/3/2009 Consumer
Primary
Concomitant
Breast Cancer Other Serious 10/1/1997 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 2/1/2001 Female 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Male 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 8/17/2009 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 75 Female 8/17/2009 Consumer United States
Primary
Secondary
Breast Cancer Female Other Serious 2/1/2001 Female 146 lb 8/27/2009 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 8/3/2000 Female 148 lb 8/28/2009 Lawyer United States
Primary
Secondary

Drug Data